Zhejiang Huakang Pharmaceutical Co., Ltd.
SSE:605077.SS
15.09 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 434.211 | 2,128.373 | 1,040.423 | 1,243.504 | 248.784 | 175.213 | 184.311 | 68.582 | 61.927 |
| Short Term Investments
| 0.028 | 461.972 | 0.224 | 70.05 | -0.247 | -0.444 | -11.866 | -12.663 | -5.899 |
| Cash and Short Term Investments
| 434.239 | 2,590.345 | 1,040.647 | 1,313.554 | 248.784 | 175.213 | 184.311 | 68.582 | 61.927 |
| Net Receivables
| 795.71 | 500.314 | 392.941 | 242.549 | 173.602 | 206.384 | 201.628 | 127.723 | 112.555 |
| Inventory
| 697.387 | 282.044 | 279.062 | 199.739 | 151.415 | 164.079 | 124.974 | 80.512 | 51.378 |
| Other Current Assets
| 647.869 | 42.214 | 425.501 | 46.809 | 25.499 | 13.651 | 6.104 | 11.971 | 76.021 |
| Total Current Assets
| 2,575.206 | 3,414.917 | 2,138.15 | 1,802.652 | 599.3 | 559.329 | 517.017 | 291.788 | 301.88 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 3,587.758 | 2,014.124 | 1,355.073 | 991.296 | 704.182 | 489.508 | 442.361 | 328.962 | 328.66 |
| Goodwill
| 346.157 | 346.157 | 26.111 | 26.111 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 305.874 | 282.646 | 242.46 | 90.064 | 55.189 | 56.589 | 31.329 | 28.254 | 35.354 |
| Goodwill and Intangible Assets
| 652.031 | 628.803 | 268.571 | 116.175 | 55.189 | 56.589 | 31.329 | 28.254 | 35.354 |
| Long Term Investments
| 93.458 | 94.422 | 122.304 | -11.489 | 53.709 | 41.471 | 55.902 | 49.707 | 12.899 |
| Tax Assets
| 23.529 | 8.127 | 3.955 | 7.374 | -53.709 | -41.471 | 0.891 | 2.615 | 2.295 |
| Other Non-Current Assets
| 60.048 | 17.29 | 16.985 | 97.987 | 71.01 | 48.58 | 0.641 | 0.838 | 1.036 |
| Total Non-Current Assets
| 4,416.823 | 2,762.765 | 1,766.888 | 1,201.343 | 830.381 | 594.677 | 531.124 | 410.377 | 380.243 |
| Total Assets
| 6,992.029 | 6,177.682 | 3,905.039 | 3,003.995 | 1,429.681 | 1,154.006 | 1,048.142 | 702.165 | 682.123 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 1,046.213 | 311.536 | 311.699 | 228.072 | 194.993 | 203.078 | 120.252 | 178.199 | 175.236 |
| Short Term Debt
| 150.299 | 552.52 | 322.453 | 119.82 | 102.751 | 155.085 | 297.078 | 208.2 | 273.307 |
| Tax Payables
| 49.264 | 32.345 | 6.964 | 5.438 | 23.265 | 17.297 | 33.766 | 13.295 | 5.707 |
| Deferred Revenue
| 0 | 0 | 12.047 | 106.681 | 69.319 | 49.876 | 33.766 | 36.696 | 64.448 |
| Other Current Liabilities
| 427.381 | 125.36 | 116.362 | 93.816 | 50.913 | 32.841 | 138.236 | 56.074 | 64.616 |
| Total Current Liabilities
| 1,673.157 | 1,021.762 | 769.526 | 455.724 | 379.371 | 401.441 | 526.981 | 455.768 | 518.865 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 1,862.655 | 1,868.498 | 345.964 | 21.481 | 53.434 | 38.771 | 55.837 | 37.896 | 24.08 |
| Deferred Revenue Non-Current
| 118.276 | 94.214 | 51.366 | 38.4 | 25.263 | 25.105 | 18.468 | 19.971 | 2.542 |
| Deferred Tax Liabilities Non-Current
| 82.617 | 92.189 | 74.372 | 53.951 | 33.854 | 14.7 | 5.417 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 8 | 0 | 2.774 | 11.844 | 0.59 | 20.507 | 0.543 |
| Total Non-Current Liabilities
| 2,063.548 | 2,054.9 | 479.703 | 113.832 | 110.788 | 67.759 | 80.243 | 58.403 | 27.165 |
| Total Liabilities
| 3,736.705 | 3,076.662 | 1,249.228 | 569.556 | 490.159 | 469.2 | 607.224 | 514.171 | 546.031 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 305.881 | 234.608 | 228.458 | 163.184 | 87.42 | 87.42 | 87.42 | 75.02 | 75.02 |
| Retained Earnings
| 1,200.745 | 1,095.188 | 891.922 | 698.47 | 601.905 | 377.016 | 158.714 | 23.216 | -25.155 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 137.283 | 109.363 | 85.782 | 105.354 | 194.783 | 89.561 | 86.018 |
| Other Total Stockholders Equity
| 1,736.806 | 1,759.637 | 1,398.148 | 1,463.422 | 164.414 | 115.014 | 194.798 | 89.561 | 0 |
| Total Shareholders Equity
| 3,243.431 | 3,089.433 | 2,655.811 | 2,434.439 | 939.522 | 684.805 | 440.918 | 187.797 | 135.884 |
| Total Equity
| 3,255.324 | 3,101.02 | 2,655.811 | 2,434.439 | 939.522 | 684.805 | 440.918 | 187.994 | 136.093 |
| Total Liabilities & Shareholders Equity
| 6,992.029 | 6,177.682 | 3,905.039 | 3,003.995 | 1,429.681 | 1,154.006 | 1,048.142 | 702.165 | 682.123 |